New diabetes clinical trial: A Study to Test the Effect of BI 456906 on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Published on: October 10, 2023 at 11:00PM
Conditions: Obesity
Interventions: Drug: BI 456906; Drug: Placebo
Sponsors: Boehringer Ingelheim
Not yet recruiting
https://ift.tt/VQ0m2dU